Skip to content
Study details
Enrolling now

Glycemic Regulation as Endometriosis Adjunct Treatment

Boston Children's Hospital
NCT IDNCT06611501ClinicalTrials.gov data as of Apr 2026
Phase

Phase 2

Target enrollment

14

Study length

about 1.7 years

Ages

15–35

Sex

Female only

Locations

1 site in MA

What this study is about

Researchers are testing if metformin hydrochloride helps with pelvic pain in women with endometriosis. The trial will compare metformin to a placebo (a sugar pill) over 6 months to see if metformin reduces pain symptoms and changes inflammatory markers.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Take Metformin Hydrochloride
  • 2.Take Placebo

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Oral

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Drug classes

Blood Glucose Regulators (Insulin Receptor Agonists)

Drug routes

oral (Oral Tablet)

Endpoints

Primary: Change in emotional functioning assessed by Beck Depression Inventory-II (BDI) over 6 months, Change in pain assessed by the Brief Pain Inventory Interference Scale (BPI) over 6 months, Change in pain severity measured by Visual Analog Scale (VAS) over 6 months

Secondary: Change in quality of life, measured via Endometriosis Health Profile-30 (EHP-30)

Body systems

Reproductive Health